3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
21
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Cisplatin
32
Gemcitabine
21
Radiotherapy, Intensity-Modulated
16
toripalimab
14
Capecitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
9
Radiotherapy
7
Drug Therapy
7
pembrolizumab
6
Platinum
6
Nivolumab
6
Immune Checkpoint Inhibitors
6
1,2-diaminocyclohexaneplatinum II citrate
6
Docetaxel
5
tislelizumab
4
spartalizumab
4
camrelizumab
4
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
nimotuzumab
2
fludarabine
2
atezolizumab
2
Taxes
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Interleukin-2
×
1 year
×
Clear all
No trials found.